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Squamous carcinoma of the oropharynx presents with symptoms common to many benign diseases, and this can cause delay in
referral to secondary care. We investigate delay in referral, defining this as the time from symptom-onset to date of general
practitioners referral letter to secondary care, and the effect of that delay, using a retrospective case notes based study of patients
presenting at our institution with oropharyngeal squamous carcinoma between 1995 and 2005. Using correlation analysis and ordinal
regression, we examined the relationship between increased referral delay from primary care, clinical stage at presentation, and
survival. Increasing time from symptom onset to referral to secondary care was positively correlated with more advanced disease
stage at presentation (rs¼þ0.346, P¼0.004). This was confirmed with ordinal regression modelling (delay estimate¼0.045,
P¼0.042). Patients with delay of less than 6 weeks had significantly improved survival compared to those with a delay of greater than
6 weeks (P¼0.032). For every 1 week of delay in referral, we estimate that the stage of presentation will progress by 0.045 of
‘a stage’.
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Head and neck squamous cell carcinoma (HNSCC) comprises 3%
of new cancer diagnoses per year in the UK (BAO-HNS, 2002).
Oropharyngeal HNSCC comprises mainly tumours of the base of
tongue, pharyngeal tonsils, soft palate, and uvula. Less common
sites are posterior pharyngeal wall, tonsillar pillars, and glosso-
tonsillar sulci. Oropharyngeal HNSCC has an incidence of
1.7:100000 in the Eastern region of the UK with a male to female
ratio of 2.6:0.8 (ECRIC, 1999). The disease shows notable
geographic variation: for example, the Calvados region in France
has an incidence of 13.9:100000 (Peckham et al, 1995). Many
patients present with nonspecific symptoms, such as sore throat or
neck nodes. Five-year survival rates are related to stage at
presentation, stage I tumours having a 67% 5-year survival, stage
IV 15–19% (Peckham et al, 1995). The majority of patients tend to
present in advanced stage, with a worse prognosis (Dhooge et al,
1996).
Owing to the relative rarity of the tumour, the average general
practitioner (GP) is not likely to see more than one case in his
professional lifetime. Thus, the index of suspicion is low. By
contrast the presenting symptoms – generally sore throat and/or
neck nodes – are common, nonspecific and shared with commoner
benign conditions such as viral pharyngitis or tonsillitis. Thus,
many patients are treated by courses of antibiotics for weeks or
months causing a delay in referral to secondary care, generally to
an ENT specialist.
Delays in the referral of these patients to secondary care are a
problem worldwide. Four papers have examined the delay from
symptom-onset to various times in the care pathway. Scully et al
(1986) found a mean delay of 3.5 months from first symptom
awareness to referral from primary care in oral cancer patients,
although Onizawa et al (2003), also in oral cancer patients, found a
mean of 2.7 months to diagnosis. Jones et al (2002) in head and
neck cancer patients found a mean 4.9 months to presentation at
secondary care. Amir et al (1999) studied within-patient-delay
specifically and found a mean 7.4 weeks for oral cancer patients
and 12.3 weeks for other head and neck cancers. None of these
authors analysed the relation between delay and tumour stage or
patient survival.
For clarity, delays in the referral and treatment pathway can be
divided into five stages: (1) Patient delay in seeking medical advice
(within-patient delay). (2) Primary care delay in referral to a
specialist up till the date of GP referral (within-GP delay), that is,
time from first presentation to GP with symptom to date of referral
letter. (3) Delay from referral letter to time of specialist
appointment. (4) Delay from specialist appointment to results of
investigations (principally endoscopy, histology, and scans). (5)
Delay from results being available to start of treatment.
In the UK, referrals of suspected new cases of cancer from
primary care to a specialist have been subject to a ‘2-week rule’
since the year 2000 (NHS Executive, 1999) (Appendix A). All
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ssuspected cancer cases are required to be seen within 2 weeks of
referral from their GP. Since 2000, there has also been improved
national funding of oncology services and two new targets which
have been recently introduced: a 1-month target from decision on
treatment to start of treatment and a two-month target from GP
referral (in urgent cases) to treatment (Great Britain, Department
of Health, 2000). Since the year 2000 is the median year of our
study period, the time from GP referral to start of treatment is
likely to be much shorter in the period 2000–2005 than it was in
1995–2000. As far as the patient is concerned, the crucial period is
the overall time from start of symptoms to start of treatment, but
we felt that the analysis of this might be biased by changes in the
period from GP referral to treatment (stages 3, 4, and 5 in the delay
pathway above) in the latter 5 years. Apart from this, the within-
patient delay plus the within-GP delay (stages 1 and 2 in the delay
pathway as above) make up the predominant part of the overall
delay.
For these reasons, we have concentrated on the sum of the first
two stages of delay in this study. We have called this period ‘delay
in referral’ hereafter in this paper and have analysed it relation to
tumour stage and patient survival.
METHODS
This was a retrospective case notes-based study covering the 10
years from June 1995 to June 2005. Patients were identified from
the Department of Oncology computerised database. This pro-
duced 110 cases of squamous carcinoma of the oropharynx, the
notes of whom were examined and the following information
searched for age, gender, site of primary cancer, date of symptom
onset, date of referral from primary care, TNM stage at
presentation, presenting symptom(s), any treatment given in
primary care (to see if treatment given in primary care influenced
delay), and outcome. Sources for the data were referral letter from
primary care, case notes from first outpatient consultation usually
ENT, and oncology notes. In 19 cases, the required information
could not be reliably sourced in the notes (see below) and in a
further 17 cases the notes could not be located and these patients
were excluded. A further four cases were excluded because the
referral was not from primary care (since we wished to study only
those cases referred by the primary care-secondary care route),
and a further one for whom the cancer was a recurrence, leaving 69
cases for analysis. Two cases had incomplete staging data and were
excluded from staging analysis. A consort diagram shows this
schematically (Figure 1).
In order to extract the data on delay in referral for each patient
as precisely as possible, it was necessary to find the time-difference
between the date of first symptom and the date of GP’s letter
referring patient to secondary care. The latter date was easy to find
in the patient’s notes, but the former was more problematic. If the
GP’s letter stated clearly the time, for example, ‘patient complains
of sore throat for past 6 weeks’ or ‘since beginning of April’, this
time was noted. If the GP’s letter was vague on this issue, then the
ENT records were searched and if this gave the date of first
symptom, this was noted. If the ENT record also failed to give the
date, then the oncology record was searched (this was uncommon)
and its date used if it was named precisely. If none of the GP letter,
ENT (or other secondary care) or the oncology record gave reliable
information, the patient was excluded.
The data for delay in referral was right skewed, and not normally
distributed (visual inspection of histogram and Shapiro–Wilk
test); therefore, a Naperian log (ln) transformation was applied,
and this gave a normal distribution. To test for differences between
groups, the independent samples t-test (for two grouping
variables) and one-way ANOVA (for three grouping variables)
were used, on the ln transformed data. Spearman’s rank
correlation and PLUM ordinal regression were used to check for
any association between delay in referral and stage at presentation,
which are nonparametric tests and could be used on the original
data. Outcome (survival) was assessed using Kaplan–Meier
survival analysis, and the log-rank test. Statistical analysis was
carried out using SPSS v12.0
s (SPSS Inc., Chicago, USA). Graphs
were prepared using SPSS
s and GraphPad Prism v4.3
s (GraphPad
software, San Diego, USA), both for Microsoft Windows XP
s.
Statistical advice was given by Econometrics Department at
University of East Anglia.
RESULTS
In the sample group, the average age at presentation was 57.5
(range 38–81, SE of mean 1.46), 54 were male, 15 female. The male
to female ratio was 3.6:1. Six patients presented with stage II
tumours, 16 with stage III, 35 with stage IVA, and 10 with stage
IVB. No stage I or stage IVC tumours were identified. With regard
to site, 43 were tonsil tumours, 19 posterior tongue, and seven
other sites (uvula and palate).
Data were analysed with reference to factors recorded from the
case notes. No significant difference was detected with regard to
gender, tumour site, presenting symptom, or treatment given in
primary care. Frequencies of presenting symptoms were (%): neck
lump (49.3), sore throat (33.3), direct visualisation (5.9), incidental
finding at medical appointment (2.9), otalgia (2.9), dysphagia (2.9),
and globus symptoms (1.4).
We examined the relationship between delay in referral and
stage at presentation (Figure 2). Although stage is an ordinal
variable, it is representative of an underlying trend, so a stage IVA
tumour can be considered to have progressed from a Stage III. In
order to examine the correlation between delay in referral and
stage at presentation, since delay in referral was not normally
distributed, and stage is an ordinal variable, we used Spearman’s
rank correlation (Table 1). This gave a correlation coefficient (rs)
of þ0.309, which when n¼67, gives a two-tailed P-value of 0.011,
that is significant. Therefore, there is a positive relationship (not
necessarily linear) between increased delay in referral and more
advanced stage at presentation. To examine this further, we
performed an ordinal regression analysis using PLUM (PoLy-
tomous Universal Model). Since the distribution of the delay in
referral is right-skewed the negative log–log is the appropriate link
function (SPSS website). The model fitting information shows that
110 cases identified from 
database
17 cases notes not 
database
19 cases information 
in notes insufficient
4 cases not referred 
from primary care
69 
cases included in study
4 case was a recurrence
70
74
93
Figure 1 Consort diagram for case selection.
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sthe null hypothesis: that all the variable coefficients are equal to
zero is false (P¼0.028). The goodness of fit tests are greater than
0.05, indicating that the model fits the data well. Parameter
estimates showed the estimate for delay in referral to be 0.045 and
the corresponding significance test gave P¼0.042. Thus, there is a
positive relationship between increased delay in referral and
advanced stage at presentation, significant at the 0.05 level. Put
another way, for every 1-week increase in delay in referral, it is
estimated that the stage at presentation will progress by 0.045 of ‘a
stage’. Mean referral times by stage are shown (Figure 2).
In order to test the possibility that delay in referral might affect
outcome, we performed survival analysis comparing two groups
with different durations of delay in referral (6 weeks or less,
compared to greater than 6 weeks). Six weeks was chosen as a
cutoff point, since this was felt to be a typical guide time from the
onset of symptoms to the decision to refer. Kaplan–Meier survival
curves are shown in Figure 3. Log-rank test showed that the group
with less than 6 weeks delay had significantly better survival
(P¼0.032). In our study, proportional hazards for both groups are
assumed, as there is no difference in management policy for each
group.
DISCUSSION
Our results show that there is a significant relationship between
delay from onset of symptoms to referral to a specialist centre, and
stage at presentation. As presenting stage affects overall survival,
this delay will be expected to impact on patient outcome, and this
is reflected in our survival data. As many of the initial symptoms of
oropharyngeal HNSCC are nonspecific, patients may delay in
seeking advice from their GP. When presenting symptoms are
more specific or worrying to the patient, such as painful ulceration
or bleeding, presentation tends to be earlier (Kowalski et al, 1994).
When nonspecific symptoms are due to minor illness they are
usually of limited duration, but persistence of symptoms may
indicate more sinister pathology. Delay in diagnosis is one of the
most common reasons for litigation in HNSCC (Lydiatt, 2002,
2004).
The retrospective case note based design of the study introduces
a potential for inaccuracy, since we are solely reliant on the data
available in the notes. As described above, cases from whose notes
a reasonably precise date of first symptom could not be
extrapolated were excluded. Even cases whose notes said ‘a few
weeks’ were excluded, since this could mean anywhere from 2 to 6
weeks. If the notes said, for example, ‘4 months’, this was taken as
17 weeks, although there is an inherent inaccuracy since the time
could have been from 3.5 to 4.5 months. We regard our data as
accurate to about 2 weeks. A prospective patient questionnaire-
based study would give more accurate information but would take
many years to complete. We therefore regard our work as a pilot,
which can identify a potential area of concern for future study.
Previous studies examining delay in referral and diagnosis of
oral and oropharyngeal carcinoma have not shown a correlation
between delay and more advanced stage at presentation (Robinson
et al, 1984; Guggenheimer et al, 1989; Merletti et al, 1990;
Jovanovic et al, 1992; Gorsky and Dayan, 1995; Dhooge et al, 1996;
Hollows et al, 2000; Onizawa et al, 2003). However, none of these
authors concentrated on the within-patient delay or the within-
primary care delay, whose sum is likely to be longer than the time
from specialist referral to starting treatment. Ours is the first study
to analyse delay from symptom onset to specialist referral in this
particular type of tumour, which tends to present late, and may
explain why our findings are positive while others are not.
Other factors are important in tumour stage at presentation,
such as biological behaviour, and some have proposed in other
tumour sites that this is more important than delay (Symonds
et al, 2000). One study examining delay to treatment in
endometrial cancer in fact showed an inverse relationship between
delay and survival (Crawford et al, 2002). This may be due to more
biologically aggressive tumours (those with shorter cell cycle time)
being seen and treated earlier, yet still having a worse prognosis,
but these authors did not look at the time from the first symptom.
Finally, since reducing delay in referral should result in these
tumours being seen in secondary care at an earlier stage, there
should be financial implications. Oropharyngeal tumours in stages
I–II are generally given single-modality, but stages III–IV
multimodality, treatment. Also, patients in stages in stages III–
IV are more likely to relapse and require palliative care. For both
of these reasons reducing delay in referral by increasing patient
and GP awareness of this disease should reduce health costs, as
well as saving patients’ lives.
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Figure 2 Mean delay (in weeks) by clinical stage at presentation (error
bars represent 95% confidence interval of mean).
Table 1 Correlations for delay vs stage at presentation
Delay
(weeks)
Clinical stage at
presentation
Spearman’s
rho
Delay
(weeks)
Correlation
coefficient
1.000 0.309 (*)
Sig. (two-tailed) 0.011
N 67 67
*Correlation is significant at the 0.05 level (two-tailed).
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Figure 3 Kaplan–Meier survival analysis of patients with a greater than 6
weeks delay in referral compared to patients with less than 6 weeks delay.
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sCONCLUSIONS
Our study in oropharyngeal squamous carcinoma shows a positive
association between delay in referral, more advanced stage at first
presentation, and shorter survival. While other factors such as
tumour biology also determine stage at presentation, more
national efforts should be made to reduce delay in referral.
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Appendix A
Department of Health, November 1999.
Guidelines for urgent referral of patients with suspected
cancer
Head and neck cancer
  Ulceration of oral mucosa persisting for 42–3 weeks
  Hoarseness persisting for 42–3 weeks
  Dysphagia persisting for 2–3 weeks
  Unresolving neck masses for 2–3 weeks
  Cranial neuropathies
  Orbital masses
The level of suspicion is further increased if the patient is a
heavy smoker or heavy alcohol drinker, and is aged over 45 years.
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